1 / 20

Human Genomic Variation

Human Genomic Variation. The Story of SNPs. Single Nucleotide Polymorphisms (SNPs). In addition to variation in microsatellites (VNTRs), genetic variation takes the form of SNPs (point mutations) The SNP Map Working Group has identified about 1.5 million SNPs

dolloff
Télécharger la présentation

Human Genomic Variation

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Human Genomic Variation The Story of SNPs

  2. Single Nucleotide Polymorphisms (SNPs) • In addition to variation in microsatellites (VNTRs), genetic variation takes the form of SNPs (point mutations) • The SNP Map Working Group has identified about 1.5 million SNPs • There is about 1 SNP / 2 kb of genome • Each ethnic group has its own collection • SNPs have been classified as major or minor, depending on frequency

  3. Is a SNP really a SNP? • False positives can result from 1) inclusion of paralogs and 2) errors in sequencing • Warren Gish at Wash U. developed a procedure to minimize false SNPs • Initially, 80,469 SNP candidates were found in 1.3 Mb of finished sequence • Paralogs were identified by their high frequency of variation (1 base in 50, instead of 1 in 1000) • This left 69,756 positions, only 59 of which were given a high probability of not resulting from sequencing error (20 were later confirmed)

  4. SNP Prevalence & Importance • 98% of all genes are within 5 kb of a SNP • 93% of all genes contain at least 1 SNP • 59% of all genes have 5 or more SNPs • 39% of all genes have 10 or more SNPs • How is SNP data useful? • the study of evolution • DNA fingerprinting • markers to map polygenic traits • developing genotype-specific medication

  5. SNPs and Disease • Linkage- how close 2 loci are on a chromosome • Linkage disequilibrium- when 2 alleles are inherited together more often than expected • Haplotype- the set of alleles on a chromosome Each person has 2 haplotypes in a given region If we track SNPs that are in linkage disequilibrium and correlate this with a disease phenotype, we have identified SNP markers that form a particular haplotype associated with this disease

  6. Two Populations with Different Frequencies of a Disease

  7. Polygenic Traits • For monogenic traits, there are 3 different genotypes • For polygenic traits, there are 3N different genotypes • Traits that are polygenic but can be measured in some quantitative way can be mapped to QTL (Quantitative Trait Loci) • Traits such as schizophrenia, high blood pressure, diabetes, cancer and Alzheimer’s may someday be mapped to QTL

  8. One Polygenic Trait: Hypomagnesemia • People with this disease are unable to maintain sufficient levels of Mg in their blood • One contributing factor is the Na/K pump • ATPase of this protein is composed of a, b & g subunits (the former is the actual pump) • A family which carried this disease had a SNP which mapped to 11q23 (the g subunit) • The SNP changed Gly to Arg in the only transmembrane domain. • Caused all 3 subunits to localize to cytoplasm

  9. Mitochondrial SNPs • >50 disease-causing SNPs map to mitochondria • Phenotypes mostly affect cardiac & skeletal muscle • 13 genes required for ETC are encoded by mitochondria, as are 22 tRNA and 2 rRNA • 2000 patients suspected of having diseases caused by mitochondrial SNPs were screened • 108 had known SNPs • More SNPs may be yet to be discovered or some diseases may not be due to SNPs

  10. Incorrect mRNA Splicing • BRCA1 has been linked to breast cancer • SNPs which do not alter the aa sequence of a protein are considered “silent” • Adrian Krainer (CSH) identified SNPs which lead to alternate splicing • 5’, 3’ ends of exons as well as internal sequences contribute to splicing • ESEs are exonic splicing enhancers and ESSs are exonic splicing silencers • SNPs in these regions lead to breast cancer

  11. Nondisease SNPs • “What is food to some men may be fierce poison to others” - Lucretius Caro • About 10% of people experience RBC lysis upon consuming fava beans • These people lack G6P dehydrogenase • Fava beans act to increase a RBC’s sensitivity to oxidants such as H2O2 • NADPH is required to break down H2O2 • RBC’s produce NADPH using G6PD, which is encoded on the X chromosome

  12. G6PD SNPs • 20% of Mediterranean population has 563C » T (no activity) • 20% of African population has 202G » A (reduces activity by 10%) • 20% of African males have 376A » G (produces normal activity)

  13. Response to Medications • Many drugs must be metabolized to intermediates before they become active • Optimum dosage for drugs is determined for the “average” person • People can typically be divided into poor, typical, and ultra-rapid metabolizers • Cytochrome P450 is one enzyme used for drug metabolism • This enzyme is encoded for by two genes, 2C19 & 2D6

  14. SNPs in Cytochrome P450 • 2D6 has 12 SNPs that have been identified • G » A in exon 4 is the most common, it leads to inactivity • >40 different drugs require 2D6 to become active, including: antiarrhythmics, opioids, antidepressants, and antipsychotics • 2C19 is required to metabolize mephenytoin, an epilepsy drug • While only 2% of Caucasians have a 681G » A SNP, 23% of Asians have this SNP

  15. Pharmacogenomics • The study of a gene which affects drug metabolism, transport, or reception is called pharmacogenetics • The study of all genes in this category is another of the “omics” sciences • Traditional drug development was aimed at delivering medications which were safe and effective for everyone • Now, genome-specific medicine may be developed which is more effective in individuals with specific SNP combinations

  16. Two Classes of Drug Metabolizing Enzymes

  17. Efficacy vs. Toxicity for a Drug • Drug response is usually polygenic • Response determined by just 2 alleles (ie. metabolism & receptor) will have 9 (32) genotypes • Different #s of people will experience a therapeutic vs. a toxic effect, depending on genotype

  18. mmRR mmRr mmrr MmRR MmRr Mmrr MMRR MMRr MMrr

  19. You Don’t Need a SNP to Inactivate Cytochrome P450! • Cytochrome P450 3A is used to convert drugs to a form that will be excreted • Grapefruit juice contains an unknown component which destroys this enzyme • 1 glass can block activity for about 24 hours • While normal breakfast amounts slightly elevated levels of a cholesterol-lowing drug, concentrated juice 3 times a day increased concentrations by 12 fold!

More Related